Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20226 (
TATA-binding protein
)
1,297
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Endotoxin-induced cytokine gene transcription in monocytes and macrophages is regulated in part by NF-kappaB. We have previously shown that the p38 mitogen-activated protein (MAP) kinase is necessary for endotoxin-induced cytokine gene transcription. Due to the fact that most cytokine promoter sequences have active NF-kappaB sites, we hypothesized that the
p38 MAP kinase
was necessary for NF-kappaB-dependent gene expression. We found that NF-kappaB-dependent gene expression was reduced to near control levels with either SB 203580 or a dominant-negative
p38 MAP kinase
expression vector. Inhibition of the
p38 MAP kinase
did not alter NF-kappaB activation at any level, but it significantly reduced the DNA binding of
TATA-binding protein
(
TBP
) to the TATA box. The dominant-negative
p38 MAP kinase
expression vector interfered with the direct interaction of native TFIID (
TBP
) with a co-transfected p65 fusion protein. Likewise, this dominant-negative plasmid also interfered with the direct interaction of a co-transfected
TBP
fusion protein with the native p65 subunit. The p38 kinase also phosphorylated TFIID (
TBP
) in vitro, and SB 203580 inhibited phosphorylation of TFIID (
TBP
) in vivo. Thus, the
p38 MAP kinase
regulates NF-kappaB-dependent gene transcription, in part, by modulating activation of TFIID (
TBP
).
...
PMID:The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). 1052 78
Activator protein 1 (AP-1) binds to the promoters of many genes involved in immune and inflammatory responses. We have previously shown that the p38 mitogen-activated protein (MAP) kinase regulates NF-kappa B-dependent gene expression by modulating the phosphorylation and subsequent activation of
TATA-binding protein
(
TBP
). In this study, we asked whether the
p38 MAP kinase
regulated the transcriptional activity of AP-1. We found that phorbol 12-myristate 13-acetate (PMA) was unable to drive the AP-1-dependent reporter gene in THP-1 cells. PMA activated both the extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase MAP kinases, but it did not activate the
p38 MAP kinase
. We found that cells expressing MAP kinase kinase 6(Glu), which is the upstream kinase that activates the
p38 MAP kinase
, had significantly increased AP-1-dependent gene expression alone and when stimulated with PMA. These cells also had increased phosphorylation of native c-Jun, suggesting that both c-Jun NH(2)-terminal kinase and p38 MAP kinases phosphorylate c-Jun. More importantly, expression of a constitutive active MAP kinase kinase 6(Glu) resulted in the phosphorylation of a His-
TBP
fusion protein and increased direct interaction of
TBP
with c-Jun. These findings suggest that in macrophages, the
p38 MAP kinase
regulates AP-1-driven transcription by modulating the activation of
TBP
.
...
PMID:The absence of activator protein 1-dependent gene expression in THP-1 macrophages stimulated with phorbol esters is due to lack of p38 mitogen-activated protein kinase activation. 1145 54